Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
US7544374B2 · kind B2 · utility
9Cited by
47References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 9, 2002 |
| Grant date | Jun 9, 2009 |
| Priority date | — |
| Expiry date | Feb 27, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Lipidated glycosaminoglycan particles are prepared by reacting a glycosaminoglycan with at least one lipid to cross-link the carboxylic acid groups in the glycosaiminoglycan with a primary amine in the lipid. These particles can be used to encapsulate active ingredients, such as drugs for use in the treatment of pathological conditions in an animal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.